Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV003231113 | SCV003929626 | pathogenic | not provided | 2022-11-30 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 26269718, 21533266, 9829910) |
| Labcorp Genetics |
RCV003511987 | SCV004296664 | pathogenic | Tuberous sclerosis 2 | 2023-10-19 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln1089*) in the TSC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TSC2 are known to be pathogenic (PMID: 10205261, 17304050). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of tuberous sclerosis complex (PMID: 9829910). ClinVar contains an entry for this variant (Variation ID: 49589). For these reasons, this variant has been classified as Pathogenic. |
| Tuberous sclerosis database |
RCV000042850 | SCV000066646 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation |